Literature DB >> 31471718

Treatment of Recurrent Pulmonary Arteriovenous Malformations: Comparison of Proximal Versus Distal Embolization Technique.

Lucas R Cusumano1, Gary R Duckwiler1, Dustin G Roberts1, Justin P McWilliams2.   

Abstract

PURPOSE: To examine the characteristics of recurrent pulmonary arteriovenous malformations (PAVMs) and compare the success of proximal versus distal embolization technique for treatment of recanalized PAVMs. MATERIALS: Between July 2007 and October 2018, 26 consecutive patients underwent embolization of 64 previously treated recurrent PAVMs at a single center with imaging follow-up. PAVM angioarchitecture was classified as either simple (1 feeding artery) or complex (≥ 2 feeding arteries). The mechanism of recurrence was characterized as recanalization (flow through previously placed embolic material) or reperfusion (flow through accessory arteries). For recanalized PAVMs, we compared embolizing proximal to or within the existing embolic (proximal embolization technique) versus embolizing distal to the existing embolic (distal embolization technique). Follow-up imaging was reviewed to determine treatment success, defined as decrease of the draining vein or sac size by at least 70%.
RESULTS: Mean patient age was 47.6 years (range 22-72 years), and 61.5% were female. Twenty-four patients (92.3%) had hereditary hemorrhagic telangiectasia, a disorder associated with PAVM formation. 31/64 (48.4%) PAVMs were simple, and 33/64 (51.6%) PAVMs were complex. Recanalization was the most common pattern of recurrence, occurring in 54/64 (84.4%) PAVMs. Treatment success following repeat embolization was 54.7% at a mean follow-up time of 1.6 years. For recanalized PAVMs, treatment success was significantly more likely with distal embolization technique (14/15, 93.3%) than with proximal embolization technique (19/33, 57.6%) (P = 0.0180).
CONCLUSION: Recurrent PAVMs are difficult to treat, with high rates of recurrence following repeat embolization. Distal embolization technique is more likely to produce durable occlusion than proximal embolization.

Entities:  

Keywords:  Embolization; Hereditary hemorrhagic telangiectasia; Pulmonary arteriovenous malformations; Recanalization; Reperfusion

Mesh:

Year:  2019        PMID: 31471718     DOI: 10.1007/s00270-019-02328-0

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  2 in total

1.  Predictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations.

Authors:  Lucas R Cusumano; Joseph A Tesoriero; Craig B Wilsen; James Sayre; Matthew Quirk; Justin P McWilliams
Journal:  Orphanet J Rare Dis       Date:  2021-11-18       Impact factor: 4.123

2.  Embolization of Recurrent Pulmonary Arteriovenous Malformations by Ethylene Vinyl Alcohol Copolymer (Onyx®) in Hereditary Hemorrhagic Telangiectasia: Safety and Efficacy.

Authors:  Salim A Si-Mohamed; Alexandra Cierco; Delphine Gamondes; Lauria Marie Restier; Laura Delagrange; Vincent Cottin; Sophie Dupuis-Girod; Didier Revel
Journal:  J Pers Med       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.